Entering text into the input field will update the search result below

EPIRUS Biopharmaceuticals beats by $0.19

  • EPIRUS Biopharmaceuticals (NASDAQ:EPRS): Q4 EPS of -$0.80 beats by $0.19.
  • Shares +5%.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
EPRS--
EPIRUS Biopharmaceuticals, Inc